Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$8,663,483
+$484,889 QoQ
Shares Held
7,223
-18.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#1,344
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $47,881,370 across 14 Drug Manufacturers - General names. LLY ranks #1 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
7,223 | $8,663,483 | |
| 2 | JNJ |
Johnson & Johnson
|
31,901 | $8,101,896 | |
| 3 | ABBV |
AbbVie Inc.
|
27,419 | $6,899,717 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,521 | $6,363,448 | |
| 5 | AMGN |
Amgen Inc
|
14,656 | $5,307,230 | |
| 6 | PFE |
Pfizer Inc
|
168,925 | $4,067,714 | |
| 7 | AZN |
Astrazeneca PLC
|
15,469 | $2,933,231 | |
| 8 | SNY |
Sanofi
|
46,110 | $1,967,052 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,663,483 | 7,223 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $8,178,594 | 8,892 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $9,273,414 | 8,629 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $6,894,468 | 9,036 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $6,703,178 | 8,599 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $7,087,959 | 8,582 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $5,536,012 | 7,171 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,338,014 | 7,154 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $6,011,723 | 6,640 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $5,171,100 | 6,647 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,987,755 | 6,841 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $3,902,786 | 7,266 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,680,220 | 5,715 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,991,492 | 5,799 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,096,994 | 5,732 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,844,065 | 5,703 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,827,684 | 5,637 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,867,418 | 6,521 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,531,916 | 5,546 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,291,569 | 5,590 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,262,589 | 5,501 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,049,367 | 5,617 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,475,155 | 8,737 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,736,718 | 11,733 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,991,010 | 12,127 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $779,190 | 5,617 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||